Antibiotics for certain viral lung infections in hospitalized adults
Part of Infections, Lungs & breathing clinical trials.
This trial studies whether giving antibiotics affects recovery in adults hospitalized with moderately severe infections caused by specific viruses (influenza, parainfluenza, RSV, or hMPV). It may help show when antibiotics are helpful or unnecessary for viral airway illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult age 18 or older and are currently hospitalized
- A swab test from your nose shows one of these viruses: influenza, parainfluenza, RSV, or hMPV
- A doctor started antibiotic treatment for you after emergency room assessment (and it was started as part of your care)
- Your illness is considered moderately severe (CRB65 score 2 or less)
- You can sign an informed consent form (or your legal representative can)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients 65 and older who are hospitalized with a respiratory virus (like flu, COVID-19, or RSV) to better understand how they recover. Researchers hope to improve care and support for older adults facing these infections.
This study tests whether a quick test for COVID-19, flu, and RSV can help doctors avoid giving antibiotics when they aren't needed. It's for people with fever or chest infection symptoms who are not sick enough to be hospitalized.
This study is testing different treatments for people with respiratory infections like the flu who are not in the hospital. You may be able to join if you have a positive test, have symptoms like cough or fever, and start within a few days of feeling sick.
This trial tests different treatments for serious lung infections in people who are already in the hospital. It may help doctors learn which treatment works best for recovery and survival when pneumonia-like illness is suspected.
This trial tests a way to give antibiotics directly to the lungs (inhaled or nebulized) for people hospitalized with moderate to severe pneumonia. The goal is to see if this local treatment works better than standard antibiotics alone and helps you recover faster.
This study tests whether giving inhaled antibiotics based on a patient's own airway bacteria can prevent ventilator-associated pneumonia (a lung infection from the breathing tube) in intensive care patients. It may help reduce infections in people who need a breathing tube for more than three days.
Hear when a new Infectious Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.